Under international accounting standards, research expenditure are not generally to be treated as an investment, and the development expenditure will only reach a series of tests in order to reflect the contribution of the company’s revenue and earnings. Thus, a relatively small amount of intangible assets appear on the balance sheets of many companies. According to KPMG and Deloitte’s analysis, confirmed intangible asset is accounted for 30% - 40% of the purchase price.
© 2018 KPMG PLT, a limited liability partnership established under Malaysian law is a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.